{"id":"W3165880262","doi":"10.1136/annrheumdis-2021-eular.390","title":"AB0521 EARLY REAL-WORLD EXPERIENCE OF TOFACITINIB FOR PSORIATIC ARTHRITIS: DATA FROM A UNITED STATES HEALTHCARE CLAIMS DATABASE","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Pfizer (Canada)","funders":"Genentech; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Tofacitinib; Janus kinase inhibitor; Apremilast; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Cohort; Physical therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001997128,0.0004034594,0.0008596375,0.001308956,0.000587145,0.002003546,0.0006540979,0.001001409,0.003173165],"category_scores_gemma":[0.00984016,0.0003330841,0.001156962,0.003310322,0.0002741354,0.001214281,0.0007362517,0.001167432,0.0008693748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001138999,"about_ca_system_score_gemma":0.001367873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0185729,"about_ca_topic_score_gemma":0.0230739,"domain_scores_codex":[0.9970763,0.000651561,0.0006759951,0.0005588437,0.0007931659,0.0002442586],"domain_scores_gemma":[0.9893537,0.003194546,0.004957923,0.0007317259,0.001137661,0.0006244397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003141074,0.000537106,0.9725443,0.0002919399,0.001401313,0.0005072235,0.000156312,0.0005828546,0.0003422004,0.0002709047,0.01112478,0.009099933],"study_design_scores_gemma":[0.000409656,0.0003467492,0.9885534,0.0001175085,0.0006334933,0.001064229,0.0002625932,0.002184415,0.0002942709,0.0001781517,0.005908032,0.00004755921],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9017284,0.002376257,0.0003545511,0.0006822068,0.00005455277,0.0001002589,0.09125742,0.00004438451,0.003402016],"genre_scores_gemma":[0.9216533,0.0007784206,0.0005433075,0.0004797425,0.00009261908,0.0001030069,0.07562126,0.00001709873,0.0007111457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0185729,"threshold_uncertainty_score":0.03692961,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1189614146598775,"score_gpt":0.3932763311999898,"score_spread":0.2743149165401123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}